Medicine – Polycystic Kidney Disease

Polycystic kidney disease is an inherited disorder in which numerous fluid-filled cysts progressively develop within the kidneys. The most important adult form is autosomal dominant polycystic kidney disease, or ADPKD, which commonly causes hypertension, haematuria, recurrent urinary problems, progressive enlargement of the kidneys, and eventual chronic kidney disease.

1. Inheritance

The classic adult form is:

Autosomal dominant polycystic kidney disease.

Therefore, an affected person has a significant chance of transmitting the condition to each child.

The major genes are:

PKD1

and

PKD2.

PKD1 disease is generally more common and often more severe.

2. Development of Renal Cysts

The original note states that:

Multiple renal cysts develop in the teenage years.

This is broadly useful but somewhat simplified.

Cysts may begin developing much earlier, but they often become progressively more numerous and clinically apparent with age. Some affected individuals remain asymptomatic until adulthood.

3. Renal Enlargement

As cysts increase in number and size, the kidneys may become:

Markedly enlarged.

The cysts arise from different parts of the nephron and progressively distort normal renal architecture.

This can eventually reduce functioning renal tissue.

4. Abdominal or Flank Pain

A common presentation is:

Abdominal, loin, or flank pain.

Pain may result from:

Cyst enlargement.

Cyst haemorrhage.

Infection.

Renal calculi.

Capsular stretching.

Some patients develop a chronic dull ache, while others present with sudden severe pain.

5. Haematuria

Patients may develop:

Microscopic or visible haematuria.

This may occur due to:

Bleeding into a cyst.

Rupture of a cyst into the collecting system.

Renal calculi.

Urinary tract infection.

Episodes of visible haematuria can be dramatic but may resolve spontaneously.

6. Urinary Tract Infection

ADPKD increases the risk of:

Urinary tract infection.

Patients may develop:

Cystitis.

Pyelonephritis.

Infected renal cysts.

Infected cysts can be particularly difficult to treat because not all antibiotics penetrate cyst fluid equally well.

7. Hypertension

Hypertension is one of the earliest and most important manifestations of ADPKD.

It may develop before there is a major reduction in GFR.

The mechanism involves:

Compression of renal vessels by expanding cysts → local renal ischaemia → renin release → RAAS activation → hypertension.

8. Importance of Hypertension

Uncontrolled hypertension contributes to:

Faster progression of CKD.

Left ventricular hypertrophy.

Cardiovascular disease.

Therefore, early recognition and treatment of blood pressure is an important part of management.

9. Chronic Kidney Disease

Progressive cyst expansion destroys and compresses normal renal tissue.

Over time this can produce:

Chronic kidney disease, or CKD.

The older term:

Renal failure

is better separated into:

CKD

and, when advanced:

End-stage kidney disease, or ESKD.

10. Progression to ESKD

Not every patient progresses at the same rate.

Progression depends on factors such as:

Genetic subtype.

Kidney size.

Blood-pressure control.

Sex.

Family history.

Episodes of haematuria or infection.

Many patients with severe disease eventually require:

Dialysis or kidney transplantation.

11. Renal Calculi

An important additional renal association is:

Kidney stones.

Patients with ADPKD have an increased risk of renal calculi, which can contribute to:

Pain.

Haematuria.

Urinary obstruction.

Infection.

12. Liver Cysts

The most common extrarenal manifestation is:

Hepatic cysts.

These often increase in number with age.

They may be asymptomatic or, if extensive, produce:

Abdominal distension.

Discomfort.

Early satiety.

Liver function is often preserved despite extensive cystic disease.

13. Pancreatic Cysts

Patients may also develop:

Pancreatic cysts.

These are less common and often asymptomatic.

Their presence supports the concept that ADPKD is a:

Systemic cystic disorder

rather than a disease confined only to the kidneys.

14. Intracranial Berry Aneurysms

A major vascular association is:

Intracranial saccular, or berry, aneurysms.

These occur more frequently in ADPKD than in the general population.

15. Subarachnoid Haemorrhage

If a berry aneurysm ruptures, it may cause:

Subarachnoid haemorrhage.

The classic presentation is:

Sudden thunderclap headache.

This may be accompanied by:

Vomiting.

Neck stiffness.

Loss of consciousness.

Focal neurological signs.

16. Who Should Be Considered for Aneurysm Screening

Routine screening of every person with ADPKD is not always performed.

Screening may be considered particularly when there is:

A family history of intracranial aneurysm or subarachnoid haemorrhage.

Previous aneurysm.

High-risk occupation.

Planned major surgery or transplantation in selected settings.

The exact approach varies by clinical guideline and patient risk.

17. Mitral Valve Prolapse

ADPKD is associated with several cardiac valvular abnormalities, including:

Mitral valve prolapse.

Other valvular abnormalities may also occur.

This reflects the systemic connective-tissue and vascular manifestations of the disorder.

18. Other Cardiovascular Associations

Additional associations can include:

Aortic root dilatation.

Aortic regurgitation.

Other arterial aneurysms in selected patients.

However, intracranial aneurysm remains the most important classic examination association.

19. Malignant Change

The original notes list:

Malignant change.

This should be interpreted cautiously.

ADPKD is not usually taught as a major direct premalignant condition in the same way as some acquired cystic kidney diseases.

Patients with advanced CKD or long-term dialysis may have increased renal cancer risk, but:

“ADPKD → malignant transformation”

is too simplistic as a core association.

20. Important Distinction – Acquired Cystic Kidney Disease

Patients with long-standing ESKD, particularly those on dialysis, may develop:

Acquired cystic kidney disease.

This condition is associated with an increased risk of:

Renal cell carcinoma.

This is different from classical inherited ADPKD.

21. Physical Examination

Some patients may have:

Bilaterally enlarged palpable kidneys.

They may also have:

Hypertension.

Abdominal masses.

Signs of CKD in advanced disease.

Large polycystic kidneys can sometimes be felt on abdominal examination.

22. Diagnosis

Diagnosis may be based on:

Family history.

Ultrasound.

CT or MRI.

Genetic testing in selected cases.

Imaging demonstrates multiple bilateral renal cysts.

23. Ultrasound

Renal ultrasound is commonly used for screening and diagnosis.

It can demonstrate:

Multiple cysts in both kidneys.

Renal enlargement.

Liver cysts.

Age-dependent imaging criteria are often used because occasional simple cysts become more common with age.

24. CT and MRI

CT or MRI can provide more detailed assessment of:

Kidney size.

Cyst burden.

Complications such as haemorrhage or stones.

MRI can also be used to estimate:

Total kidney volume

in selected patients.

25. Genetic Testing

Genetic testing for:

PKD1

and

PKD2

may be helpful when:

Imaging is equivocal.

The family history is unclear.

Living-related kidney donation is being considered.

Early diagnosis has important implications.

26. Treatment Principles

There is no simple cure for ADPKD.

Management focuses on:

Blood-pressure control.

Preservation of kidney function.

Treatment of infection.

Treatment of stones.

Management of pain.

Monitoring for complications.

27. Blood-Pressure Treatment

Good blood-pressure control is particularly important.

ACE inhibitors or ARBs are commonly used because of their effects on:

RAAS activity

and

Renal protection.

The exact target depends on patient age, kidney function, and other clinical factors.

28. Tolvaptan

A major modern disease-modifying treatment is:

Tolvaptan.

This is a:

Vasopressin V2-receptor antagonist.

In selected patients at risk of rapidly progressive ADPKD, it can slow:

Kidney enlargement

and

Decline in renal function.

29. Monitoring with Tolvaptan

Tolvaptan can cause:

Polyuria.

Thirst.

It also carries a risk of:

Liver injury.

Therefore, patients require appropriate:

Liver-function monitoring.

30. Treatment of Infection

UTIs and pyelonephritis should be treated appropriately.

If an infected renal cyst is suspected, antibiotic choice may need to consider:

Cyst penetration.

Persistent fever or pain despite treatment may require further imaging.

31. Treatment of Pain

Pain management depends on the cause.

Possible causes include:

Cyst haemorrhage.

Stone disease.

Infection.

Large cysts.

Persistent focal symptoms may occasionally require specialist interventions.

32. Treatment of Kidney Stones

Stone disease is managed according to:

Stone size.

Location.

Presence of obstruction.

Presence of infection.

Treatment may include:

Fluids.

Analgesia.

Endoscopic treatment.

Lithotripsy or other urological procedures.

33. Renal Replacement Therapy

If patients progress to ESKD, treatment options include:

Haemodialysis.

Peritoneal dialysis in suitable patients.

Kidney transplantation.

Transplantation is an important long-term option for suitable patients.

34. Family Screening

Because ADPKD is inherited, first-degree relatives may require:

Counselling.

Blood-pressure measurement.

Urinalysis.

Imaging where appropriate.

The timing and method depend on age and clinical circumstances.

35. Autosomal Recessive Polycystic Kidney Disease

It is important not to confuse ADPKD with:

Autosomal recessive polycystic kidney disease, or ARPKD.

ARPKD usually presents in:

Infancy or childhood.

It is associated with:

Collecting duct dilatation.

Congenital hepatic fibrosis.

Portal hypertension.

This is a different disorder from adult ADPKD.

36. ADPKD – Note Form

Inheritance:

Autosomal dominant.

Genes:

PKD1.

PKD2.

Kidneys:

Multiple bilateral renal cysts.

Progressive renal enlargement.

Presentations:

Abdominal or flank pain.

Microscopic or visible haematuria.

UTI.

Hypertension.

Renal stones.

CKD.

Possible progression to ESKD.

37. Extrarenal Associations – Note Form

Liver:

Hepatic cysts.

Pancreas:

Pancreatic cysts.

Brain vessels:

Berry aneurysms.

Risk of subarachnoid haemorrhage if rupture occurs.

Heart:

Mitral valve prolapse.

Other valvular abnormalities may occur.

38. Important Corrections to the Original Notes

The statement:

“Multiple renal cysts develop in teenage years”

is too fixed.

Cysts may develop earlier, but clinical and imaging expression increases progressively with age.

The statement:

“Renal failure”

is better described as:

Progressive CKD with possible ESKD.

The statement:

“Malignant change”

should not be treated as a defining classical association of ADPKD.

An especially important distinction is:

Acquired cystic kidney disease in long-term ESKD/dialysis has a clearer association with renal cell carcinoma.

The original list also omits an important renal complication:

Renal calculi.

Modern treatment should also include consideration of:

Tolvaptan in selected patients with rapidly progressive disease.

Key Clinical Pattern

Remember:

ADPKD = AUTOSOMAL DOMINANT + BILATERAL RENAL CYSTS + HYPERTENSION + HAEMATURIA + PROGRESSIVE CKD.

Important extrarenal associations are:

LIVER CYSTS.

PANCREATIC CYSTS.

BERRY ANEURYSMS → SUBARACHNOID HAEMORRHAGE.

MITRAL VALVE PROLAPSE.

A very high-yield exam pattern is:

FAMILY HISTORY + HYPERTENSION + ENLARGED CYSTIC KIDNEYS + HAEMATURIA → THINK ADPKD.

And remember:

ADPKD + THUNDERCLAP HEADACHE → URGENTLY CONSIDER RUPTURED INTRACRANIAL ANEURYSM / SUBARACHNOID HAEMORRHAGE.